Display options
Share it on

Cancer Chemother Pharmacol. 1979;3(3):161-6. doi: 10.1007/BF00262416.

Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients.

Cancer chemotherapy and pharmacology

W E Evans, C B Pratt, R H Taylor, L F Barker, W R Crom

PMID: 316744 DOI: 10.1007/BF00262416

[No abstract available.]

Cited by

References

  1. Cancer Res. 1977 Feb;37(2):445-50 - PubMed
  2. Cancer Treat Rep. 1978 Jan;62(1):178-80 - PubMed
  3. J Natl Cancer Inst. 1971 Apr;46(4):775-84 - PubMed
  4. Cancer Treat Rep. 1977 Jul;61(4):709-15 - PubMed
  5. Semin Oncol. 1977 Jun;4(2):203-16 - PubMed
  6. Cancer Treat Rep. 1977 Jul;61(4):745-8 - PubMed
  7. Cancer Chemother Rep. 1975 Jul-Aug;59(4):811-7 - PubMed
  8. Cancer Treat Rep. 1978 Mar;62(3):345-50 - PubMed
  9. Cancer Treat Rep. 1978 Feb;62(2):233-5 - PubMed
  10. J Pharm Sci. 1971 Aug;60(8):1128-33 - PubMed
  11. Cancer Treat Rep. 1977 Dec;61(9):1665-74 - PubMed
  12. Cancer Res. 1978 Feb;38(2):345-53 - PubMed
  13. Cancer Res. 1974 Dec;34(12):3326-31 - PubMed
  14. Cancer Treat Rep. 1977 Aug;61(5):797-804 - PubMed
  15. Med Pediatr Oncol. 1976;2(3):319-25 - PubMed
  16. Eur J Cancer. 1972 Aug;8(4):409-14 - PubMed
  17. N Engl J Med. 1972 Jan 27;286(4):175-9 - PubMed
  18. J Pharmacol Exp Ther. 1974 Jun;189(3):585-92 - PubMed
  19. Cancer Res. 1976 Dec;36(12):4418-24 - PubMed
  20. Clin Pharmacol Ther. 1978 Jan;23(1):68-72 - PubMed
  21. J Clin Invest. 1973 Aug;52(8):1804-11 - PubMed
  22. N Engl J Med. 1977 Sep 22;297(12):630-4 - PubMed
  23. Cancer Res. 1977 Jun;37(6):1602-7 - PubMed
  24. Cancer Treat Rep. 1977 Aug;61(5):779-83 - PubMed

Substances

MeSH terms

Publication Types